Home › Lung Cancer › Massachusetts › Lynn
Lung Cancer clinical trials in Lynn, MA
3 studies for Lung Cancer are looking for participants at sites in and around Lynn (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
RecruitingPhase 3
- Lahey Clinic Peabody, Peabody · 4 mi away
- Beverly Hospital, Beverly · 7 mi away
- Addison Gilbert Hospital, Gloucester · 18 mi away
Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial
RecruitingPhase 3
- Lahey Clinic Peabody, Peabody · 4 mi away
- Beverly Hospital, Beverly · 7 mi away
- Addison Gilbert Hospital, Gloucester · 18 mi away
Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)
RecruitingPhase 2/3
- Lahey Medical Center-Peabody, Peabody · 4 mi away
- Beverly Hospital, Beverly · 7 mi away
- Addison Gilbert Hospital, Gloucester · 18 mi away
About Lung Cancer
Lung cancer forms in tissues of the lung, usually in the cells that line the air passages. It is the leading cause of cancer death in both men and women.
More about Lung Cancer on MedlinePlus
Lung Cancer trials in other cities
- Houston, TX78 studies
- Boston, MA62 studies
- New York City, NY60 studies
- Los Angeles, CA45 studies
- Arlington, VA41 studies
- Washington, DC41 studies
- Chicago, IL41 studies
- Nashville, TN40 studies
- Baltimore, MD40 studies
- St. Louis, MO39 studies
- Columbus, OH37 studies
- Philadelphia, PA36 studies
Other studies in Lynn
- Breast Cancer5 studies
- Non-Small Cell Lung Cancer4 studies
- Kidney Cancer (Renal Cell Carcinoma)3 studies
- Acute Myeloid Leukemia3 studies
From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.